表紙
市場調査レポート

梅毒:世界の治験レビュー

Syphilis Global Clinical Trials Review, H1, 2015

発行 GlobalData 商品コード 175085
出版日 ページ情報 英文 75 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.39円で換算しております。
Back to Top
梅毒:世界の治験レビュー Syphilis Global Clinical Trials Review, H1, 2015
出版日: 2015年05月20日 ページ情報: 英文 75 Pages
概要

当レポートでは、梅毒に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、G7およびE7諸国における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んで、お届けします。

イントロダクション

  • 梅毒
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • 主要国における治験件数; アジア太平洋地域
    • 主要国における治験件数; 欧州
    • 主要国における治験件数; 北米
    • 主要国における治験件数; 中東/アフリカ地域

G7諸国における治験件数: 梅毒治験件数の感染症治験件数に対する比率

フェーズ(相)別治験件数: G7諸国

G7諸国における治験件数:フェーズ(相)別

E7諸国における治験件数:梅毒治験件数の感染症治験件数に対する比率

フェーズ(相)別治験件数:E7諸国

E7諸国における治験件数:フェーズ(相)別

フェーズ(相)別治験件数

  • フェーズ(相)別の進行中治験件数

進捗状況別の治験件数

評価項目別の治験件数

一定期間に採用された被験者数

スポンサーの種類別の治験件数

有望なスポンサー

治験主要参加企業 - 梅毒治療薬

有望な薬剤

治験のプロファイル

  • 代表的な企業の治験の概要
    • Pfizer Inc.
    • Mylan N.V.
    • Kendle International Inc. (Inactive)
    • F. Hoffmann-La Roche Ltd.
  • 代表的な研究機関/病院の治験の概要
    • Population Council
    • Centers for Disease Control and Prevention
    • The National Institute of Allergy and Infectious Diseases
    • Bronx Municipal Hospital Center
    • Chinese Academy of Medical Sciences and Peking Union Medical College
    • Far Eastern Memorial Hospital
    • L.A. Gay & Lesbian Center
    • National Taiwan University Hospital
    • Ottawa Hospital Research Institute
    • St. Joseph Hospital

5大治験プロファイル

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2684CTIDB

GlobalData's clinical trial report, "Syphilis Global Clinical Trials Review, H1, 2015" provides data on the Syphilis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Syphilis . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Syphilis . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Syphilis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Syphilis to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Syphilis to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Syphilis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Mylan N.V.
      • Clinical Trial Overview of Mylan N.V.
      • Kendle International Inc. (Inactive)
      • Clinical Trial Overview of Kendle International Inc. (Inactive)
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
    • Clinical Trial Overview of Top Institutes / Government
      • Population Council
      • Clinical Trial Overview of Population Council
      • Centers for Disease Control and Prevention
      • Clinical Trial Overview of Centers for Disease Control and Prevention
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • Bronx Municipal Hospital Center
      • Clinical Trial Overview of Bronx Municipal Hospital Center
      • Chinese Academy of Medical Sciences and Peking Union Medical College
      • Clinical Trial Overview of Chinese Academy of Medical Sciences and Peking Union Medical College
      • Far Eastern Memorial Hospital
      • Clinical Trial Overview of Far Eastern Memorial Hospital
      • L.A. Gay & Lesbian Center
      • Clinical Trial Overview of L.A. Gay & Lesbian Center
      • National Taiwan University Hospital
      • Clinical Trial Overview of National Taiwan University Hospital
      • Ottawa Hospital Research Institute
      • Clinical Trial Overview of Ottawa Hospital Research Institute
      • St. Joseph Hospital
      • Clinical Trial Overview of St. Joseph Hospital
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Syphilis Therapeutics, Global, Clinical Trials by Region, 2015*
  • Syphilis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Syphilis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Syphilis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Syphilis Therapeutics Clinical Trials, Europe, Top Countries, 2015*
  • Syphilis Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Syphilis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Proportion of Syphilis to Infectious Disease Clinical Trials, G7 Countries (%), 2015*
  • Syphilis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Syphilis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Syphilis to Infectious Disease Clinical Trials, E7 Countries (%), 2015*
  • Syphilis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Syphilis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Syphilis Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Syphilis Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Syphilis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Syphilis Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Syphilis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Syphilis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Syphilis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Syphilis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Syphilis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mylan N.V., 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by Kendle International Inc. (Inactive), 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by Population Council, 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by Centers for Disease Control and Prevention, 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bronx Municipal Hospital Center, 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese Academy of Medical Sciences and Peking Union Medical College, 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by Far Eastern Memorial Hospital, 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by L.A. Gay & Lesbian Center, 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2015*
  • Syphilis Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Joseph Hospital, 2015*

List of Figures

  • Syphilis Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Syphilis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Syphilis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Syphilis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Syphilis Therapeutics Clinical Trials, Europe, Top Countries (%), 2015*
  • Syphilis Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Syphilis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Proportion of Syphilis to Infectious Disease Clinical Trials, G7 Countries (%), 2015*
  • Syphilis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Syphilis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Syphilis to Infectious Disease Clinical Trials, E7 Countries (%), 2015*
  • Syphilis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Syphilis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Syphilis Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Syphilis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Syphilis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Syphilis Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Syphilis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Syphilis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Syphilis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Syphilis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Syphilis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top